effect of semaglutide on chronic kidney disease Research shows — commonly sold as Ozempic or Wegovy — can improve function and survival rates for people with some diseases, even if they have heart issues. ✍️ Health Chronic Kidney Disease | Ozempic®

Read more about GLP-1 Studies: Tani, Y., Tokuda, M., Nishimoto, N., Yokoi, H., & Izumori, K

Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction.

Cardiometabolic improvements also drifted back toward baseline

Products and their starting costs include: Wegovy Pill: $149/month Foundayo Pill: $149/month Wegovy Pen: $199/month Ozempic: $199/month Zepbound Vial: $299/month Zepound KwikPen: $299/month Mounjaro: $1,899/month Zepound: $1,899/month Note that because the FDA has announced it is taking action on non-FDA approved GLP-1s, you may see fewer compounded options

Comment These lesions are considered to represent a regenerative response to prior or continuous hepatocellular damage